Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Classifica tra le azioni #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Prezzo delle azioni
$97.46
Ultima sincronizzazione: 2026-10-02
Capitalizzazione di mercato
$168.63B
Variazione (1 giorno)
0.77%
Variazione (1 anno)
-27.59%
Paese
US
Scambia Abbott Laboratories (ABT)

Categoria

Utile per Abbott Laboratories (ABT)
Utile nel Jun 2026 TTM: $7.51B
Secondo gli ultimi rapporti finanziari di Abbott Laboratories, gli utili attuali della società sono $7.51B. Nel 2024, la società ha registrato un utile di $7.01B, un aumento rispetto a agli utili del 2023, che erano di $6.66B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Abbott Laboratories dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $7.51B -11.28%
2025 $8.47B 20.72%
2024 $7.01B 5.24%
2023 $6.66B -19.77%
2022 $8.31B 1.16%
2021 $8.21B 65.28%
2020 $4.97B 21.85%
2019 $4.08B 41.91%
2018 $2.87B 28.78%
2017 $2.23B 57.89%
2016 $1.41B -55.61%
2015 $3.18B 26.41%
2014 $2.52B -0.12%
2013 $2.52B -59.75%
2012 $6.26B 20.47%
2011 $5.20B -9.00%
2010 $5.71B -20.59%
2009 $7.19B 22.84%
2008 $5.86B 31.02%
2007 $4.47B 96.35%
2006 $2.28B -50.73%
2005 $4.62B 11.98%
2004 $4.13B 10.48%
2003 $3.73B 1.66%
2002 $3.67B 95.07%
2001 $1.88B -50.66%
2000 $3.82B 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$5.56B -25.94%
IE
$5.15B -31.46%
US
$3.86B -48.60%
US
- -
DE
$1.42B -81.13%
US